Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Characterization and anti-uterine tumor effect of extract from Prunella vulgaris L.

Fig. 1

Inhibition rates of PVE and GLC by MTT assay. a: Inhibition rates of treatment with varying PVE concentrations of 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 or 8.0 mg/ml at 24 h in the HUSMC cells; b: Inhibition rates of treatment with varying GLC concentrations of 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 or 9.0 mg/ml at 24 h in the HUSMC cells; c: Inhibition rates of treatment with varying PVE or GLC concentrations of 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 or 8.0 mg/ml at 24 h in the HUMC cells, compared with the GLC group, *p < 0.05

Back to article page